Johnson & Johnson (JNJ) News Today $190.88 +0.16 (+0.09%) Closing price 03:59 PM EasternExtended Trading$190.42 -0.46 (-0.24%) As of 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Johnson & Johnson Up Today?Toggle Visibility of Why Is Johnson & Johnson Up Today?Johnson & Johnson (JNJ) — Shares have ticked higher today as investors weigh an upcoming Q3 report and several company developments. Below are the key items from the last 24 hours that are driving sentiment and could move the stock around earnings. Positive Sentiment: J&J MedTech launched new Inhance Intact shoulder instrumentation, supporting the medtech growth narrative and replacing older procedure kits — a near-term product win for the MedTech unit. Johnson & Johnson MedTech launches Inhance Intact shoulder instrumentation Positive Sentiment: An analyst/price-target update raised J&J’s target (to $178 per American Banking News), and an institutional buy (Douglas Lane added ~$6M of shares) signals investor confidence ahead of earnings. These items provide incremental support to the stock. Johnson & Johnson (NYSE:JNJ) Price Target Raised to $178.00 Douglas Lane Adds $6 Million in J&J Stock Ahead of Earnings Positive Sentiment: Deal speculation: several pieces discuss J&J’s strategic interest in Protagonist Therapeutics as an M&A target — a bolt-on would be viewed positively if accretive to growth/biotech pipeline. Johnson & Johnson To Acquire Protagonist? It'd Be A Good Deal To Make Neutral Sentiment: Q3 previews and analyst notes highlight that J&J is near record highs and that investors will be focused on revenue guidance, medtech momentum, and pipeline updates; previews alone add uncertainty until results are released. Johnson & Johnson Q3 earnings on deck: What to expect Johnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To Watch Neutral Sentiment: Operational notes: analysis pieces flag improving MedTech sales in key categories but also point to headwinds in China pricing programs — mixed implications for top-line growth. Is J&J's MedTech Segment Set for Another Quarter of Growth? Negative Sentiment: Regulatory setback: the FDA added a boxed/warning to J&J’s CAR-T therapy Carvykti (with Legend Biotech) over rare immune-related enterocolitis; this raises safety scrutiny and has already pressured sentiment ahead of earnings. FDA Adds New Warning For Johnson & Johnson's Cancer Cell Therapy Negative Sentiment: Market reaction: commentary notes shares softened in early trading as the Carvykti label change landed ahead of the Q3 report — elevated pre-earnings volatility is likely. Johnson & Johnson Stock (JNJ) Falters Ahead of Earnings Release as Cancer Therapy Gets Warning Label Posted 53m agoAI Generated. May Contain Errors. JNJ Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Johnson & Johnson Q3 earnings on deck: What to expect5 hours ago | seekingalpha.comJohnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To Watch5 hours ago | benzinga.comJohnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To WatchOctober 13 at 12:27 PM | benzinga.comJohnson & Johnson Stock (JNJ) Falters Ahead of Earnings Release as Cancer Therapy Gets Warning LabelOctober 13 at 12:11 PM | tipranks.comA Peek at Johnson & Johnson's Future EarningsOctober 13 at 11:55 AM | benzinga.comFDA Adds New Warning For Johnson & Johnson's Cancer Cell TherapyOctober 13 at 10:50 AM | benzinga.comUS FDA adds label warning to J&J's and Legend Biotech's cancer therapyOctober 13 at 6:54 AM | msn.comUS FDA adds label warning to J&J's and Legend Biotech's cancer therapyOctober 13 at 6:54 AM | msn.comDrucker Wealth 3.0 LLC Has $2.10 Million Stake in Johnson & Johnson $JNJOctober 13 at 4:42 AM | marketbeat.comJohnson & Johnson $JNJ Holdings Decreased by Villere ST Denis J & Co. LLCOctober 13 at 4:42 AM | marketbeat.comEastern Bank Sells 1,876 Shares of Johnson & Johnson $JNJOctober 13 at 4:42 AM | marketbeat.comAberdeen Group plc Has $414.20 Million Holdings in Johnson & Johnson $JNJOctober 13 at 4:42 AM | marketbeat.comLmcg Investments LLC Raises Holdings in Johnson & Johnson $JNJOctober 13 at 4:42 AM | marketbeat.comZullo Investment Group Inc. Has $2.11 Million Stock Holdings in Johnson & Johnson $JNJOctober 13 at 4:42 AM | marketbeat.comCascade Investment Group Inc. Buys 1,468 Shares of Johnson & Johnson $JNJOctober 13 at 4:41 AM | marketbeat.comMonument Capital Management Grows Stake in Johnson & Johnson $JNJOctober 13 at 4:41 AM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Price Target Raised to $178.00October 13 at 2:06 AM | americanbankingnews.comDouglas Lane Adds $6 Million in J&J Stock Ahead of Earnings and Possible Biotech DealOctober 12 at 3:14 PM | fool.comJohnson & Johnson To Acquire Protagonist? It'd Be A Good Deal To MakeOctober 12 at 9:30 AM | seekingalpha.comJohnson & Johnson recommends shareholders reject "mini-tender" offer by TutanotaOctober 12 at 7:26 AM | finance.yahoo.comCyndeo Wealth Partners LLC Has $9.71 Million Stock Holdings in Johnson & Johnson $JNJOctober 12 at 4:09 AM | marketbeat.comMengis Capital Management Inc. Cuts Stock Holdings in Johnson & Johnson $JNJOctober 12 at 4:09 AM | marketbeat.comJohnson & Johnson $JNJ Position Lowered by Commerzbank Aktiengesellschaft FIOctober 12 at 4:09 AM | marketbeat.comMorton Brown Family Wealth LLC Grows Position in Johnson & Johnson $JNJOctober 12 at 4:09 AM | marketbeat.comMoseley Investment Management Inc. Trims Stock Holdings in Johnson & Johnson $JNJOctober 12 at 4:09 AM | marketbeat.comIFP Advisors Inc Reduces Stock Holdings in Johnson & Johnson $JNJOctober 12 at 4:08 AM | marketbeat.comBaldwin Wealth Partners LLC MA Sells 2,232 Shares of Johnson & Johnson $JNJOctober 12 at 4:08 AM | marketbeat.comCallan Family Office LLC Purchases 23,772 Shares of Johnson & Johnson $JNJOctober 12 at 4:01 AM | marketbeat.comBlair William & Co. IL Sells 4,804 Shares of Johnson & Johnson $JNJOctober 12 at 4:00 AM | marketbeat.comRep. Val T. Hoyle Sells Off Shares of Johnson & Johnson (NYSE:JNJ)October 11 at 8:07 AM | marketbeat.comWhat Analysts Are Saying About Johnson & Johnson StockOctober 11 at 6:54 AM | benzinga.comJohnson & Johnson $JNJ Shares Acquired by Mainstay Capital Management LLC ADVOctober 11 at 4:21 AM | marketbeat.comEdge Financial Advisors LLC Purchases New Shares in Johnson & Johnson $JNJOctober 11 at 4:21 AM | marketbeat.comLeo Wealth LLC Increases Stock Position in Johnson & Johnson $JNJOctober 11 at 4:14 AM | marketbeat.comBaxter Bros Inc. Lowers Position in Johnson & Johnson $JNJOctober 11 at 4:13 AM | marketbeat.comInsight Inv LLC Sells 16,645 Shares of Johnson & Johnson $JNJOctober 11 at 4:13 AM | marketbeat.comArmstrong Fleming & Moore Inc Boosts Stake in Johnson & Johnson $JNJOctober 11 at 4:13 AM | marketbeat.comColumbus Macro LLC Boosts Stake in Johnson & Johnson $JNJOctober 11 at 4:13 AM | marketbeat.comNotis McConarty Edward Has $5.02 Million Stake in Johnson & Johnson $JNJOctober 11 at 4:13 AM | marketbeat.comCohen Investment Advisors LLC Boosts Holdings in Johnson & Johnson $JNJOctober 11 at 4:13 AM | marketbeat.comTrifecta Capital Advisors LLC Buys 1,576 Shares of Johnson & Johnson $JNJOctober 11 at 4:13 AM | marketbeat.comJohnson & Johnson $JNJ Shares Bought by Vontobel Holding Ltd.October 11 at 4:13 AM | marketbeat.comMaryland State Retirement & Pension System Increases Stock Position in Johnson & Johnson $JNJOctober 11 at 4:03 AM | marketbeat.comMorgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight RecommendationOctober 11 at 2:54 AM | msn.comUS FDA adds boxed warning to J&J, Legend Biotech's cancer therapyOctober 10 at 6:36 PM | reuters.comJohnson & Johnson recommends shareholders reject “mini-tender” offer by TutanotaOctober 10 at 4:20 PM | businesswire.comMorgan Stanley Forecasts Strong Price Appreciation for Johnson & Johnson (NYSE:JNJ) StockOctober 10 at 2:01 PM | marketbeat.comJohnson & Johnson In Talks To Acquire Protagonist Therapeutics: ReportOctober 10 at 1:31 PM | benzinga.comM&A News: Protagonist Therapeutics Stock (PTGX) is Star of the Show on JNJ Bid TalkOctober 10 at 12:51 PM | tipranks.comJohnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reportsOctober 10 at 11:25 AM | reuters.com Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JNJ Media Mentions By Week JNJ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JNJ News Sentiment▼1.120.77▲Average Medical News Sentiment JNJ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JNJ Articles This Week▼13062▲JNJ Articles Average Week Get the Latest News and Ratings for JNJ and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Johnson & Johnson and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Intuitive Surgical News Today Moderna News Today Novavax News Today AbbVie News Today Berkshire Hathaway News Today Eli Lilly and Company News Today Merck & Co., Inc. News Today Pfizer News Today Procter & Gamble News Today Exxon Mobil News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:JNJ) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Share Johnson & Johnson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
